-
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products2023.02.28 -
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in2023.01.31 -
Oricell's GPRC5D CAR-T receives Orphan Drug Designation from FDA2022.10.26 -
OriCell Therapeutics Receives Implied License from NMPA for Ori-C101 IND Application2022.09.21 -
OriCell Therapeutics Raises Over $120 Million in Series B Financing2022.08.01 -
OriCell Reports OriCAR-017 Phase I POLARIS study Data in Oral Presentation at ASCO 20222022.06.10
